RxDoctor Payments Data

Vincent Green, MD

Family Medicine · Simpsonville, SCNPI 1366431025

Payments from drug & device makers

$119in general payments, 2019–2025

Across 7 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$36
  • Amgen$34
  • GSK$19
  • Novo Nordisk$16
  • Pfizer$13

What the payments were for

  • Food & beverage$119100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astellas Pharma US Inc2$36
Amgen2$34
GSK1$19
Novo Nordisk1$16
Pfizer1$13

How this compares

$119 in reported general payments places this provider in the 25th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$168,085
Medicare patients
263
Services billed
2,660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban94$70,025
JardianceEmpagliflozin30$43,018
OzempicSemaglutide16$31,826
FarxigaDapagliflozin Propanediol30$31,582
JanuviaSitagliptin Phosphate21$25,636
MounjaroTirzepatide14$14,671
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$7,259
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$5,130
Breo ElliptaFluticasone/Vilanterol12$5,040
Albuterol Sulfate HfaAlbuterol Sulfate102$3,257
Novolin 70-30Insulin Nph Hum/Reg Insulin Hm12$3,062
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen98$2,277
Rosuvastatin Calcium204$2,257
Atorvastatin Calcium296$2,068
Losartan Potassium185$2,028

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$13$70,02594 claims
Novo NordiskOzempic$16$31,82616 claims
GSKBreo Ellipta$19$5,04012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Simpsonville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →